Palo Alto– August 26, 2014 – Cooley LLP announced today that it maintained its market leadership for capital markets work with the announcement of its 2014 half-year statistics. Through the first six months of 2014, Cooley advised on a total of 63 completed public offerings, including 31 initial public offerings, raising more than $7.5 billion.
According to IPO Vital Signs, Cooley was the number one law firm for issuer side IPOs across all industries and for technology and life sciences IPOs. Cooley was involved in 45% of all IPOs for venture-backed companies, including 44% of life sciences offerings and 26% of technology company IPOs.
Cooley's strong Q2 followed directly on the heels of its stellar first quarter, in which it was also the number one law firm overall across all industries and advising technology and life sciences companies. Cooley also had a record 2013 in the capital markets, advising on a total of 60 completed public offerings.
Cooley's capital markets lawyers advise issuers, investment banks and investors in equity and debt transactions that raise capital through the public and private capital markets. In 2014, Cooley has handled offerings advising either the company or the underwriters on securities offerings for 2U, ACADIA Pharmaceuticals, Aerohive Networks, Castlight Health, Coupons.com, Criteo, Everyday Health, FireEye, HealthEquity, InterMune, Iridium Communications, Jazz Pharmaceuticals, Kite Pharma, MobileIron, Neurocrine Biosciences, Receptos, RingCentral, Revance, T2 Biosystems, Tableau Software, TriNet, Versartis and Zendesk, among others.
Please view the firm's 1H capital markets infographic here.
About Cooley LLP
Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.
Cooley has more than 750 lawyers across 11 offices in the United States and China.